- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Resistant Arterial Hypertension
Call for Papers
Resistant hypertension is defined as blood pressure that remains above goal in spite of the concurrent use of three antihypertensive agents of different classes. Recent studies have shown that resistant hypertension is a common disease with an estimated prevalence between 15% and 30% in treated hypertensive patients. Patients with resistant hypertension present with worse cardiovascular prognosis than those without resistant hypertension. In order to adequately plan a tailored treatment, it is necessary to discard white-coat resistant hypertension and investigate clinical and subclinical target-organ damage. Treatment of resistant hypertension is still controversial. Recent publications have focused on nonpharmacological approaches such as sodium restriction, on medicines involving combined renin-angiotensin-aldosterone system antagonists, and on surgical approaches such as renal sympathetic denervation and carotid baroreceptor stimulation.
Despite advances in clinical and surgical treatment, the estimated prevalence of resistant hypertension has increased over the last few decades and still challenges primary care clinicians and specialists. We invite authors to submit original research and review articles regarding the prevalence, pathogenesis, diagnostic evaluation, and clinical and surgical treatment of resistant hypertension. Potential topics include, but are not limited to:
- Prevalence and poor compliance
- Role of 24-hour ambulatory blood pressure monitoring
- Subclinical target-organ damage evaluation
- Nonpharmacological treatment
- Vascular function abnormalities
- Renal hypertension
- Secondary hypertension
- Combined renin-angiotensin-aldosterone system antagonists
- Renal sympathetic denervation
- Carotid baroreceptor stimulation
Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/ijht/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/ijht/rarh/ according to the following timetable:
| Manuscript Due | Friday, 25 January 2013 |
| First Round of Reviews | Friday, 19 April 2013 |
| Publication Date | Friday, 14 June 2013 |
Lead Guest Editor
- Marina Politi Okoshi, Internal Medicine Department, Botucatu Medical School, Sao Paulo State University (UNESP), Botucatu, SP, Brazil
Guest Editors
- Maria Czarina Acelajado, Section of Hypertension, Department of Medicine, University of the Philippines-Philippine General Hospital, Manila, Philippines
- Philip A. Kalra, Department of Renal Medicine, Salford Royal Hospital, Salford, UK
- Roberto Jorge Franco, Internal Medicine Department, Botucatu Medical School (UNESP), Botucatu, SP, Brazil